Header Logo

Connection

Bradley Gehrs to Bevacizumab

This is a "connection" page, showing publications Bradley Gehrs has written about Bevacizumab.
Connection Strength

0.020
  1. Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Mol Cancer Ther. 2009 Jul; 8(7):1867-77.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.